Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Antibodies for prevention of mother-to-child transmission of HIV-1.

Fouda GG, Moody MA, Permar SR.

Curr Opin HIV AIDS. 2015 May;10(3):177-82. doi: 10.1097/COH.0000000000000150. Review.

2.

HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission.

Voronin Y, Mofenson LM, Cunningham CK, Fowler MG, Kaleebu P, McFarland EJ, Safrit JT, Graham BS, Snow W.

PLoS Med. 2014 Apr 8;11(4):e1001616. doi: 10.1371/journal.pmed.1001616. eCollection 2014 Apr.

3.
4.

Immunology of pediatric HIV infection.

Tobin NH, Aldrovandi GM.

Immunol Rev. 2013 Jul;254(1):143-69. doi: 10.1111/imr.12074. Review.

5.

Immunotherapies to prevent mother-to-child transmission of HIV.

Hicar MD.

Curr HIV Res. 2013 Mar;11(2):137-43. Review.

6.

Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro.

Farzin A, Boyer P, Ank B, Nielsen-Saines K, Bryson Y.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):77-83. doi: 10.1089/AID.2011.0355. Epub 2012 Dec 7.

7.

Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).

Onyango-Makumbi C, Omer SB, Mubiru M, Moulton LH, Nakabiito C, Musoke P, Mmiro F, Zwerski S, Wigzell H, Falksveden L, Wahren B, Antelman G, Fowler MG, Guay L, Jackson JB.

J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):399-407. doi: 10.1097/QAI.0b013e31822f8914.

8.

Treatment interruption after pregnancy: effects on disease progression and laboratory findings.

Watts DH, Lu M, Thompson B, Tuomala RE, Meyer WA 3rd, Mendez H, Rich K, Hanson C, LaRussa P, Diaz C, Mofenson LM.

Infect Dis Obstet Gynecol. 2009;2009:456717. doi: 10.1155/2009/456717. Epub 2009 Nov 2.

9.

Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda.

Onyango-Makumbi C, Bagenda D, Mwatha A, Omer SB, Musoke P, Mmiro F, Zwerski SL, Kateera BA, Musisi M, Fowler MG, Jackson JB, Guay LA.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):20-7.

10.

Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.

Menezes EV, Yakoob MY, Soomro T, Haws RA, Darmstadt GL, Bhutta ZA.

BMC Pregnancy Childbirth. 2009 May 7;9 Suppl 1:S4. doi: 10.1186/1471-2393-9-S1-S4.

11.

Immunoprophylaxis against mother-to-child transmission of HIV-1.

Gorny MK, Zolla-Pazner S.

PLoS Med. 2006 Jul;3(7):e259. Epub 2006 Jul 18. No abstract available.

12.

Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.

Lambert JS, Moye J Jr, Plaeger SF, Stiehm ER, Bethel J, Mofenson LM, Mathieson B, Kagan J, Rosenblatt H, Paxton H, Suter H, Landay A.

Clin Diagn Lab Immunol. 2005 May;12(5):622-31.

13.

Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.

Haigwood NL, Montefiori DC, Sutton WF, McClure J, Watson AJ, Voss G, Hirsch VM, Richardson BA, Letvin NL, Hu SL, Johnson PR.

J Virol. 2004 Jun;78(11):5983-95.

14.

A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil.

Lambert JS, Nogueira SA, Abreu T, Machado ES, Costa TP, Bondarovsky M, Andrade M, Halpern M, Barbosa R, Perez M.

Sex Transm Infect. 2003 Dec;79(6):448-52.

15.

The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Farquhar C, John-Stewart G.

Clin Exp Immunol. 2003 Dec;134(3):367-77. Review. No abstract available.

16.

Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.

Hemming VG.

Clin Diagn Lab Immunol. 2001 Sep;8(5):859-63. Review. No abstract available.

17.
18.
19.

Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women.

Patterson BK, Behbahani H, Kabat WJ, Sullivan Y, O'Gorman MR, Landay A, Flener Z, Khan N, Yogev R, Andersson J.

J Clin Invest. 2001 Feb;107(3):287-94.

20.

Mother-to-infant transmission of HIV-1: the placenta fights back.

Spector SA.

J Clin Invest. 2001 Feb;107(3):267-9. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk